HP57-2-2012-eng.pdf - Publications du gouvernement du Canada

2 downloads 221 Views 2MB Size Report
... of Canada. Provincial and Territorial Public Health Microbiology Laboratories ..... Multi-drug resistance (3 or more
National Surveillance of Invasive Streptococcus pneumoniae and Streptococcus pyogenes In Canada Annual Summary 2012

Streptococcus and STI Unit Bacteriology and Enteric Diseases Program National Microbiology Laboratory Public Health Agency of Canada

Vaccine Preventable Diseases Centre for Immunization and Respiratory Infectious Diseases Public Health Agency of Canada

Provincial and Territorial Public Health Microbiology Laboratories

To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health. — Public Health Agency of Canada

Également disponible en français sous le titre : Surveillance nationale en laboratoire de Streptococcus pneumoniae et Streptococcus pyogenes au Canada : Rapport sommaire annuel de 2012

To obtain additional copies, please contact: Streptococcus and STI Unit Bacteriology and Enteric Diseases Program National Microbiology Laboratory Canadian Science Centre for Human and Animal Health Public Health Agency of Canada 1015 Arlington Street, Room H2600 Winnipeg, Manitoba R3E 3R2 Tel: (204) 789-6063 Fax: (204) 789-5012 [email protected] This publication can be made available in alternative formats upon request. © Her Majesty the Queen in Right of Canada, as represented by the Minister of Health Canada, 2013 Publication date: December 2013 This publication may be reproduced for personal or internal use only without permission provided the source is fully acknowledged. However, multiple copy reproduction of this publication in whole or in part for purposes of resale or redistribution requires the prior written permission from the Minister of Public Works and Government Services Canada, Ottawa, Ontario K1A 0S5 or [email protected].

Cat.: HP57-2/2012E-PDF ISSN: 2292-2709 Pub.: 130509

3| Invasive Streptococcus pneumoniae and Streptococcus pyogenes – Annual Summary 2012

AUTHORSHIP Streptococcus and STI Unit Bacteriology and Enteric Diseases Program National Microbiology Laboratory Public Health Agency of Canada Walter H.B. Demczuk, Averil Griffith, Ravinder Singh, Irene Martin (Unit Head) Dr. Michael Mulvey (A/Director)

Other Contributors: Vaccine Preventable Diseases Section Surveillance and Outbreak Response Division Centre for Immunization and Respiratory Infectious Diseases Public Health Agency of Canada Dr. Heather Deehan, Dr. Shalini Desai, Lindsey Sherrard Laboratoire de santé publique du Québec Dr. Brigitte Lefebvre, Dr. Marc-Christian Domingo, Dr. Cecile Tremblay Toronto Invasive Bacterial Diseases Network Department of Microbiology, Mount Sinai Hospital Dr. Allison McGeer, Agron Plevneshi, Sylvia Pong-Porter, Karen Green, Kenny Wong and site investigators and staff The Alberta Provincial Laboratory for Public Health (Microbiology), Dr. Gregory J. Tyrrell, Marguerite Lovgren, Dr. Graham Tipples Department of Medical Microbiology and Infectious Diseases, Faculty of Medicine, University of Manitoba Dr. Heather Adam, Dr. Matthew Gilmour, Melanie Baxter, Kim Nichol, Barbara Weshnoweski, Ravi Vashisht, Dr. George Zhanel This report has been reviewed by Canadian Public Health Laboratory Network (CPHLN) Provincial and Territorial laboratory Directors.

ACKNOWLEDGEMENTS The results presented in this report represent streptococcal isolates kindly submitted to the NML from the following hospitals or provincial public health laboratories: British Columbia Centre for Disease Control, Vancouver, British Columbia – Dr. Judy Issac-Renton, Dr. Linda Hoang, Ingrid Pocock, Ana Paccagnella, Loretta Janz, Sultana Mithan, Tazim Rahim; Saskatchewan Disease Control Laboratory, Regina, Saskatchewan - Dr. Greg Horsman, Rosanne Kitzul; Cadham Provincial Laboratory, Winnipeg, Manitoba - Dr. Jared Bullard, Dr. Paul Van Caeseele, Denise Sitter; Public Health Laboratories, Ontario Agency for Health Protection and Promotion, Etobicoke, Ontario – Dr. Francis Jamieson, Dr. Jonathan Gubbay, Prasad Rawte; Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia - Dr. David Haldane; New Brunswick Regional Hospitals - Dr. Alexander Doroshenko, Maryse Thibeault, Eric Brisson, Francine Plourde, Dr. L. Thibault, Dr. Lewis Abbott, Melanie Stace, Peter Delaney, Linda Turgeon, Tammy Mahaney; Queen Elizabeth Hospital, Charlottetown, Prince Edward Island – Dr. G. German; Newfoundland Public Health Laboratory, St. John’s, Newfoundland - Dr. S. Ratnam; Stanton Territorial Hospital Laboratory, Yellowknife, Northwest Territories - Cheryl Case; Whitehorse General Hospital, Whitehorse, Yukon - Rosalyn Robertson, Becky Nash, Chris Cash.

4| Invasive Streptococcus pneumoniae and Streptococcus pyogenes – Annual Summary 2012

TABLE OF CONTENTS Acknowledgements ..................................................................................................... 3 Executive Summary..................................................................................................... 7 Introduction ................................................................................................................. 8 Methods ...................................................................................................................... 9 Results and Discussion ............................................................................................... 11 Streptococcus pneumoniae ................................................................................. 11 Antimicrobial Resistance ..................................................................................... 29 Streptococcus pyogenes (Group A Streptococcus).............................................. 32 Conclusion .................................................................................................................. 37 Appendices (Raw Data Tables) ................................................................................... 38 References .................................................................................................................. 46

FIGURES AND TABLES Figure 1. Incidence of IPD, 2000 – 2012................................................................................ 8 Figure 2. Incidence of IPD cases per 100 000 in Canada, 2008 – 2012 ................................. 11 Table 1.

Number of invasive S. pneumoniae isolates from each province, 2012.................... 13

Figure 3. Clinical isolation sites of S. pneumoniae, 2012........................................................ 14 Figure 4. Distribution of invasive S. pneumoniae by clinical source, 2012 .............................. 14 Figure 5. Invasive S. pneumoniae serotypes in Canada, 2010 – 2012 .................................. 15 Figure 6. Invasive S. pneumoniae serotypes in < 2 year olds, 2010 – 2012 ........................... 15 Figure 7. Invasive S. pneumoniae serotypes in 2 – 4 year olds, 2010 – 2012 ........................ 16 Figure 8. Invasive S. pneumoniae serotypes in 5 – 14 year olds, 2010 – 2012 ...................... 16 Figure 9. Invasive S. pneumoniae serotypes in 15 – 49 year olds, 2010 – 2012 .................... 17 Figure 10. Invasive S. pneumoniae serotypes in 50 – 64 year olds, 2010 – 2012 .................... 17 Figure 11. Invasive S. pneumoniae serotypes in ≥ 65 year olds, 2010 – 2012 ......................... 18 Figure 12. Serotype 19A by age .............................................................................................. 19 Figure 13. Serotype 7F by age ................................................................................................ 19 Figure 14. Serotype 3 by age .................................................................................................. 19

5| Invasive Streptococcus pneumoniae and Streptococcus pyogenes – Annual Summary 2012

Figure 15. Serotype 22F by age .............................................................................................. 19 Figure 16. Regional distribution of invasive S. pneumoniae serotypes, 2012............................ 21 Figure 17. Regional distribution of invasive S. pneumoniae serotypes in